Daniel Wacker

8.5k total citations · 6 hit papers
34 papers, 4.0k citations indexed

About

Daniel Wacker is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Daniel Wacker has authored 34 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 6 papers in Organic Chemistry. Recurrent topics in Daniel Wacker's work include Receptor Mechanisms and Signaling (20 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Neuropeptides and Animal Physiology (9 papers). Daniel Wacker is often cited by papers focused on Receptor Mechanisms and Signaling (20 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Neuropeptides and Animal Physiology (9 papers). Daniel Wacker collaborates with scholars based in United States, Germany and China. Daniel Wacker's co-authors include Bryan L. Roth, Raymond C. Stevens, Vadim Cherezov, Vsevolod Katritch, Tao Che, Gye Won Han, Xi‐Ping Huang, Brian K. Shoichet, Sheng Wang and Eyal Vardy and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Daniel Wacker

33 papers receiving 4.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure of the human κ-opioid receptor in complex with JDTic

2012 718 citations Huixian Wu, Daniel Wacker et al. Nature profile →
Structural Features for Functional Selectivity at Serotonin Receptors

2013 543 citations Daniel Wacker, Chong Wang et al. Science profile →
How Ligands Illuminate GPCR Molecular Pharmacology

2017 400 citations Daniel Wacker, Raymond C. Stevens et al. Cell profile →
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone

2018 331 citations Sheng Wang, Tao Che et al. Nature profile →
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor

2020 306 citations Kuglae Kim, Tao Che et al. Cell profile →
Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions

2020 252 citations Daniel Wacker, Jian Jin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Wacker United States	19	3.2k	2.1k	610	477	311	34	4.0k
Marta Filizola United States	40	4.3k 1.4×	3.0k 1.4×	456 0.7×	569 1.2×	313 1.0×	140	5.7k
Wesley K. Kroeze United States	27	2.8k 0.9×	1.9k 0.9×	592 1.0×	185 0.4×	310 1.0×	38	4.9k
John D. McCorvy United States	30	3.0k 0.9×	2.5k 1.2×	508 0.8×	316 0.7×	790 2.5×	71	4.9k
Tao Che United States	24	2.3k 0.7×	1.2k 0.6×	751 1.2×	284 0.6×	398 1.3×	69	3.5k
Vincent Setola United States	33	2.8k 0.9×	1.8k 0.8×	1.2k 2.0×	185 0.4×	634 2.0×	81	5.1k
Ryan T. Strachan United States	25	2.6k 0.8×	1.5k 0.7×	251 0.4×	380 0.8×	92 0.3×	31	3.4k
Meritxell Canals Australia	44	4.5k 1.4×	3.5k 1.7×	343 0.6×	495 1.0×	120 0.4×	113	6.6k
Enric I. Canela Spain	58	5.6k 1.8×	4.5k 2.1×	180 0.3×	323 0.7×	186 0.6×	201	9.3k
J. Robert Lane United States	38	4.5k 1.4×	2.8k 1.4×	803 1.3×	608 1.3×	378 1.2×	101	5.8k

Countries citing papers authored by Daniel Wacker

Since Specialization

Citations

This map shows the geographic impact of Daniel Wacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wacker more than expected).

Fields of papers citing papers by Daniel Wacker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Wacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wacker. The network helps show where Daniel Wacker may publish in the future.

Co-authorship network of co-authors of Daniel Wacker

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Wacker. A scholar is included among the top collaborators of Daniel Wacker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Wacker. Daniel Wacker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Warren, Audrey L., et al.. (2025). Structural determinants of G protein subtype selectivity at the serotonin receptor 5-HT1A. Science Advances. 11(31). eadu9851–eadu9851. 2 indexed citations

Wacker, Daniel & John D. McCorvy. (2025). Biased Signaling in Psychedelic Action. The Annual Review of Pharmacology and Toxicology. 66(1). 241–260.

Warren, Audrey L., et al.. (2024). Molecular basis of human trace amine-associated receptor 1 activation. Nature Communications. 15(1). 108–108. 14 indexed citations

Warren, Audrey L., et al.. (2024). Structural insights into the unexpected agonism of tetracyclic antidepressants at serotonin receptors 5-HT _1e R and 5-HT _1F R. Science Advances. 10(16). eadk4855–eadk4855. 3 indexed citations

Warren, Audrey L., Michael J. Cunningham, Lyonna F. Parise, et al.. (2024). Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature. 630(8015). 237–246. 39 indexed citations

Wacker, Daniel & Marta Filizola. (2024). Can Targeting the Sodium Site via Water Molecules Lead to the Development of Safer Opioids?. ACS Central Science. 10(8). 1436–1438. 1 indexed citations

McCorvy, John D., et al.. (2023). Molecular insights into GPCR mechanisms for drugs of abuse. Journal of Biological Chemistry. 299(9). 105176–105176. 4 indexed citations

Wacker, Daniel, et al.. (2023). Computational characterization of the binding mode and mechanism of action of tricyclic small molecules at 5-HT1E and 5-HT1F receptors. Biophysical Journal. 122(3). 509a–510a. 1 indexed citations

Warren, Audrey L., et al.. (2023). Discovery and characterization of antidepressant mediated activation of 5-HT1E and 5-HT1F receptors. Biophysical Journal. 122(3). 195a–195a. 1 indexed citations

10.

Sakloth, Farhana, Anne Ruiz, Randal A. Serafini, et al.. (2022). A Regional and Projection-Specific Role of RGSz1 in the Ventrolateral Periaqueductal Grey in the Modulation of Morphine Reward. Molecular Pharmacology. 103(1). 1–8. 4 indexed citations

11.

Kim, Kuglae, Tao Che, Ouliana Panova, et al.. (2020). Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor. Cell. 182(6). 1574–1588.e19. 306 indexed citations breakdown →

12.

Che, Tao, Justin G. English, B. Krumm, et al.. (2020). Nanobody-enabled monitoring of kappa opioid receptor states. Nature Communications. 11(1). 1145–1145. 93 indexed citations

13.

English, Justin G., Reid H. J. Olsen, Katherine Lansu, et al.. (2019). VEGAS as a Platform for Facile Directed Evolution in Mammalian Cells. Cell. 178(3). 748–761.e17. 72 indexed citations

14.

McCorvy, John D., Daniel Wacker, Sheng Wang, et al.. (2018). Structural determinants of 5-HT2B receptor activation and biased agonism. Nature Structural & Molecular Biology. 25(9). 787–796. 116 indexed citations

15.

Wang, Sheng, Tao Che, Anat Levit, et al.. (2018). Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone. Nature. 555(7695). 269–273. 331 indexed citations breakdown →

16.

Wacker, Daniel, Raymond C. Stevens, & Bryan L. Roth. (2017). How Ligands Illuminate GPCR Molecular Pharmacology. Cell. 170(3). 414–427. 400 indexed citations breakdown →

17.

Wacker, Daniel, Chong Wang, Vsevolod Katritch, et al.. (2013). Structural Features for Functional Selectivity at Serotonin Receptors. Science. 340(6132). 615–619. 543 indexed citations breakdown →

18.

Wu, Huixian, Daniel Wacker, Mauro Mileni, et al.. (2012). Structure of the human κ-opioid receptor in complex with JDTic. Nature. 485(7398). 327–332. 718 indexed citations breakdown →

19.

Thompson, Aaron A., Jeffrey J. Liu, Eugene Chun, et al.. (2011). GPCR stabilization using the bicelle-like architecture of mixed sterol-detergent micelles. Methods. 55(4). 310–317. 73 indexed citations

20.

Fuhrmann, D., Daniel Wacker, K. Weiß, et al.. (1998). The adsorption of small hydrocarbons on Cu(111): A combined He-atom scattering and x-ray absorption study for ethane, ethylene, and acetylene. The Journal of Chemical Physics. 108(6). 2651–2658. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact